THE EFFECT OF INTERFERON AND RIBAVIRIN TREATMENT ON HEARING LEVELS IN PATIENTS WITH CHRONIC HEPATITIS C

ŞENOL A., Aksakal G., Akin M., Yariktas M., Gören İ., Isler M.

NOBEL MEDICUS, cilt.12, sa.1, ss.35-38, 2016 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 1
  • Basım Tarihi: 2016
  • Dergi Adı: NOBEL MEDICUS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.35-38
  • Anahtar Kelimeler: Chronic hepatitis C, interferon alfa, ribavirin, hearing, PEGYLATED INTERFERON/RIBAVIRIN, COMBINATION THERAPY, INITIAL TREATMENT, ALPHA-INTERFERON, PLUS RIBAVIRIN, PEGINTERFERON
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Objective: Combination of interferon (IFN) alfa and ribavirin therapy is widely used for the treatment of chronic hepatitis C. Various side effects such as flu like symptoms, depression, autoimmune tiroiditis, vertigo, skin rashs, acute myocarditis and bone marrow supression may be seen with this therapy, however, the effect on hearing levels is not clearly evaluated. In this study, we investigated the effect of IFN alfa-2b and ribavirin combination therapy on the hearing levels in patients with chronic hepatitis C.